EXAFS spectroscopic evidence for an Fe O unit in the Fe (IV) intermediate observed during oxygen activation by taurine: α-ketoglutarate dioxygenase
…, JC Price, RB Guyer, JH Brehm… - Journal of the …, 2004 - ACS Publications
The Fe(II)- and α-ketoglutarate-dependent dioxygenases catalyze hydroxylation reactions of
considerable biomedical and environmental significance. Recently, the first oxidized iron …
considerable biomedical and environmental significance. Recently, the first oxidized iron …
[HTML][HTML] A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals
FA Procopio, R Fromentin, DA Kulpa, JH Brehm… - …, 2015 - thelancet.com
Background Quantifying latently infected cells is critical to evaluate the efficacy of therapeutic
strategies aimed at reducing the size of the long-lived viral reservoir, but the low frequency …
strategies aimed at reducing the size of the long-lived viral reservoir, but the low frequency …
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
…, S Maguire, B Liao, EP Browne, RG Ferris, JH Brehm… - Nature, 2020 - nature.com
Long-lasting, latently infected resting CD4 + T cells are the greatest obstacle to obtaining a
cure for HIV infection, as these cells can persist despite decades of treatment with …
cure for HIV infection, as these cells can persist despite decades of treatment with …
The immunological synapse: the gateway to the HIV reservoir
DA Kulpa, JH Brehm, R Fromentin… - Immunological …, 2013 - Wiley Online Library
… ki67 and CD38 expression on memory CD4 + T cells and preservation of the Tcm subset
were observed after a 7-day culture in the presence of Wnt3a and anti-CD3/CD28 (JH Brehm …
were observed after a 7-day culture in the presence of Wnt3a and anti-CD3/CD28 (JH Brehm …
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells
DA Kulpa, A Talla, JH Brehm, SP Ribeiro… - Journal of …, 2019 - Am Soc Microbiol
During antiretroviral therapy (ART), human immunodeficiency virus type 1 (HIV-1) persists
as a latent reservoir in CD4 + T cell subsets in central memory (T CM ), transitional memory (T …
as a latent reservoir in CD4 + T cell subsets in central memory (T CM ), transitional memory (T …
[HTML][HTML] Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
C Gavegnano, JH Brehm, FP Dupuy, A Talla… - PLoS …, 2017 - journals.plos.org
Despite advances in the treatment of HIV infection with ART, elucidating strategies to overcome
HIV persistence, including blockade of viral reservoir establishment, maintenance, and …
HIV persistence, including blockade of viral reservoir establishment, maintenance, and …
Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3′-azido-3 …
JH Brehm, D Koontz, JD Meteer, V Pathak… - Journal of …, 2007 - Am Soc Microbiol
Recent work indicates that mutations in the C-terminal domains of human immunodeficiency
virus type 1 (HIV-1) reverse transcriptase (RT) increase 3′-azido-3′-dideoxythymidine (…
virus type 1 (HIV-1) reverse transcriptase (RT) increase 3′-azido-3′-dideoxythymidine (…
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors
JH Brehm, DL Koontz, CL Wallis… - Clinical infectious …, 2012 - academic.oup.com
Background. It is not known how often mutations in the connection and ribonuclease H
domains of reverse transcriptase (RT) emerge with failure of first-line antiretroviral therapy (ART) …
domains of reverse transcriptase (RT) emerge with failure of first-line antiretroviral therapy (ART) …
Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance
JH Brehm, JW Mellors, N Sluis-Cremer - Biochemistry, 2008 - ACS Publications
We recently reported that zidovudine (AZT) selected for the Q509L mutation in the ribonuclease
H (RNase H) domain of HIV-1 reverse transcriptase (RT), which increases resistance to …
H (RNase H) domain of HIV-1 reverse transcriptase (RT), which increases resistance to …
[HTML][HTML] The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription
AA Okoye, R Fromentin, H Takata, JH Brehm… - PLoS …, 2022 - journals.plos.org
Activation of the NF-κB signaling pathway by Protein Kinase C (PKC) agonists is a potent
mechanism for human immunodeficiency virus (HIV) latency disruption in vitro. However, …
mechanism for human immunodeficiency virus (HIV) latency disruption in vitro. However, …